GLYGENIX THERAPEUTICS
GlyGenix Therapeutics, Inc. develops therapeutic products for the treatment of cure metabolic disorders. The company manufactures and delivers genes to cure GSD1a. It has partnerships with National Institutes of Health, Duke University, University of Florida, and Royal Philips Electronics. GlyGenix Therapeutics, Inc. was founded in 2006 and is based in Woodbridge, Connecticut.
GLYGENIX THERAPEUTICS
Industry:
Biotechnology Manufacturing Residential Therapeutics
Founded:
2006-01-01
Address:
Woodbridge, Connecticut, United States
Country:
United States
Website Url:
http://www.glygenixtherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
2033975821
Email Addresses:
[email protected]
Total Funding:
150 K USD
Technology used in webpage:
InMotion Hosting InMotion Hosting DNS
Similar Organizations
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Connecticut Innovations
Connecticut Innovations investment in Seed Round - GlyGenix Therapeutics
Official Site Inspections
http://www.glygenixtherapeutics.com
Unable to get host informations!!!
More informations about "GlyGenix Therapeutics"
GLY Genix - Overview, News & Competitors | ZoomInfo.com
Based in Woodbridge, CT, GlyGenix Therapeutics, Inc. is a privately held biotech company developing therapeutic solutions for severe metabolic disorders. The company's initial focus is …See details»
GlyGenix Therapeutics - Products, Competitors, Financials, …
GlyGenix Therapeutics's mission is focused on the development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen Storage Disease Type 1a. …See details»
GlyGenix Therapeutics Inc - Company Profile and News
Company profile page for GlyGenix Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
GlyGenix Therapeutics Inc Company Profile, Financial and
GlyGenix Therapeutics, Inc. develops therapeutic products for the treatment of cure metabolic disorders. The company manufactures and delivers genes to cure GSD1a. It has partnerships …See details»
Glygenix Therapeutics - F6S
Verified Glygenix Therapeutics employees can claim the page to update it Similar companies Geneix Passionate about personalising medications Soligenix Rising to the challenges of rare …See details»
GlyGenix Therapeutics – CheckOrphan
GlyGenix Therapeutics, Inc.'s mission is focused on the development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen Storage Disease Type 1a. …See details»
Glygenix Therapeutics Inc, Woodbridge, CT - 15 Research Drive ...
Glygenix Therapeutics Inc is a privately held company in Woodbridge, CT and is a Single Location business. Categorized under Research and Development Laboratories. Our records show it …See details»
GlyGenix Therapeutics - Contacts, Employees, Board Members
GlyGenix Therapeutics has 1 current employee profile, CFO Ramesh Ratan. GlyGenix Therapeutics has 8 board members and advisors, including Adrienne Block . ContactsSee details»
GlyGenix Therapeutics, Inc. - Company Information - 6sense.com
Find useful insights on GlyGenix Therapeutics, Inc.'s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at GlyGenix …See details»
GlyGenix Therapeutics - VentureRadar
GlyGenix Therapeutics VentureRadar profile. Find out more about GlyGenix Therapeutics including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
GlyGenix Therapeutics - Crunchbase
GlyGenix Therapeutics develops therapeutic products for the treatment of cure metabolic disorders.See details»
GlyGenix Therapeutics - Company Profile - Tracxn
GlyGenix Therapeutics - Provider of gene therapies for glycogen storage diseases. This company is not active anymore. Raised a total funding of $2.67M over 2 rounds from 1 investor. …See details»
GlyGenix Therapeutics Inc. - BioCentury Company Profiles - BCIQ
Aug 10, 2009 GlyGenix Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
GlyGenix Therapeutics Inc. Company Profile- Outlook, Business …
2 GLYGENIX THERAPEUTICS, INC- SNAPSHOT 2.1 GlyGenix Therapeutics, Inc- Overview 2.2 Business Strategies and Outlook 2.3 Stock Information 3 GLYGENIX THERAPEUTICS, INC- …See details»
GlyGenix Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... Seed Round - GlyGenix Therapeutics . 1: obfuscated. …See details»
AAV-G6Pase gene therapy (GlyGenix Therapeutics)
Literatures (Medical) associated with AAV-G6Pase gene therapy (GlyGenix Therapeutics) 01 Jun 2013 · Molecular genetics and metabolism Q2 · BIOLOGY Pathogenesis of growth failure and …See details»
GlyGenix Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. GlyGenix Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. About. …See details»
GlyGenix Therapeutics Reviews | Read Client Reviews of GlyGenix ...
Read reviews of GlyGenix Therapeutics. Write and share your personal story. Your experience will help others make the right buying decision. Trustburn. Categories Log in For business. …See details»
Adrienne Block - Member of the Board of Directors - Crunchbase
Dr. Adrienne Block has been working with GlyGenix Therapeutics since it was founded in 2006. She is also a founding member of The UCAN Company. Prior to the Bayer Healthcare …See details»